Treatment with benfotiamine in patients with diabetic sensorimotor polyneuropathy: A double-blind, randomized, placebo-controlled, parallel group pilot study over 12 months-Reference-Cited by-同舟云学术

Treatment with benfotiamine in patients with diabetic sensorimotor polyneuropathy: A double-blind, randomized, placebo-controlled, parallel group pilot study over 12 months

Published:2020-12 Issue:12 Volume:34 Page:107757
ISSN:1056-8727
Container-title:Journal of Diabetes and its Complications
language:en
Short-container-title:Journal of Diabetes and its Complications

Author:

Stirban Ovidiu Alin,Zeller-Stefan Helga,Schumacher Jochen,Gaus Wilhelm,Ziegler Dan,Schuerholz Thomas,Pop-Busui Rodica

Funder

Wörwag Pharma GmbH & Co. KG

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference2 articles.

1. Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study;Stracke;Exp Clin Endocrinol Diabetes,2008

2. A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy;Stracke;Exp Clin Endocrinol Diabetes,1996

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetic neuropathy: Current issues in diagnosis and prevention;Chronic Complications of Diabetes Mellitus;2024

2. Diabetischer Fuß: Fokus auf die Neuropathie;Info Diabetologie;2022-09

3. Reactive Oxygen Species Scavenging Nanomedicine for the Treatment of Ischemic Heart Disease;Advanced Materials;2022-07-28

4. BOND study: a randomised double-blind, placebo-controlled trial over 12 months to assess the effects of benfotiamine on morphometric, neurophysiological and clinical measures in patients with type 2 diabetes with symptomatic polyneuropathy;BMJ Open;2022-02

5. Linderung bei Kribbeln und Schmerz;Info Diabetologie;2021-10